Table 2.

A gene dosage effect: % positivity of antiglycan antibodies in CD patients carrying zero, one and two NOD2/CARD15 variants

	CD patients with 0 NOD2/CARD15 variant	CD patients with 1 NOD2/CARD15 variant	CD patients with 2 NOD2/CARD15 variants	P	Ref.
gASCA	51.50	64.20	72.30	< 0.0001	51
	41.60	64.60	67.50	< 0.0001	22
ALCA	34.90	42.10	46.70	< 0.04	51
AMCA	9.80	14.10	30	< 0.001	22
Any antiglycan	52.40	69.70	80	< 0.0001	22